Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding.

Autor: Asleh R; Departments of Cardiovascular Diseases., Albitar HAH; Internal Medicine., Schettle SD; Departments of Cardiovascular Diseases., Kushwaha SS; Departments of Cardiovascular Diseases., Pereira NL; Departments of Cardiovascular Diseases., Behfar A; Departments of Cardiovascular Diseases., Stulak JM; Division of Cardiovascular Surgery., Rodeheffer RJ; Departments of Cardiovascular Diseases., Iyer VN; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: iyer.vivek@mayo.edu.
Jazyk: angličtina
Zdroj: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2020 May; Vol. 39 (5), pp. 492-495. Date of Electronic Publication: 2020 Feb 24.
DOI: 10.1016/j.healun.2020.02.012
Databáze: MEDLINE